VOGLI 0.3 10'S

About

VOGLI 0.3, containing Voglibose 0.3 mg, is an alpha-glucosidase inhibitor used in the management of type 2 diabetes mellitus. Its primary mechanism of action involves delaying the digestion and absorption of carbohydrates from the gastrointestinal tract. By inhibiting alpha-glucosidase enzymes in the small intestine, Voglibose slows down the breakdown of complex carbohydrates into simpler sugars, thereby reducing the rapid rise in blood glucose levels that typically occurs after meals (postprandial hyperglycemia).

This medication is particularly effective in controlling post-meal blood sugar spikes, which are a significant contributor to overall glycemic dysregulation in diabetic patients. It can be used as monotherapy or in combination with other oral antidiabetic agents or insulin, when diet and exercise alone are insufficient to achieve adequate glycemic control. Regular monitoring of blood glucose and HbA1c levels is crucial to assess the therapeutic response and ensure optimal management of diabetes, helping to reduce the risk of long-term complications.

Uses

• Management of type 2 diabetes mellitus.
• Control of postprandial hyperglycemia.
• As monotherapy or adjunct to other antidiabetics.
• Improved overall glycemic control.

Directions For Use

Take this medication orally immediately before or with the first bite of each main meal, as directed by your physician.

Benefits

• Effective control of post-meal blood sugar spikes.
• Significant reduction in HbA1c levels.
• Helps prevent rapid glucose absorption.
• Can be used in combination therapy.
• Improved overall glycemic control.
• Well-tolerated with minimal systemic absorption.

Side Effects

• Flatulence
• Diarrhea
• Abdominal pain
• Bloating
• Nausea
• Vomiting
• Constipation
• Indigestion
• Headache
• Dizziness
• Skin rash
• Hypoglycemia (when combined with other agents)

Safety Measures

• Alcohol - Use alcohol with caution as it can affect blood sugar levels. No direct interaction with Voglibose, but general diabetic advice applies.
• Pregnancy - Generally not recommended during pregnancy. Consult your doctor; insulin is often preferred for glycemic control in pregnant women.
• Breastfeeding - Not recommended during breastfeeding as Voglibose may pass into breast milk and potentially affect the infant.
• Liver - Use with caution in patients with severe liver impairment. Regular monitoring of liver function may be advised.
• Kidney - Use with caution in patients with severe kidney impairment. Dose adjustment may be necessary.
• Lung - No specific contraindications related to lung conditions, but general caution for patients with severe chronic illnesses.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.